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pathogen through homeostasis of the
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Microbiota-mediated effects on the host immune
response facilitate colonization resistance against
pathogens. However, it is unclear whether and how
the host immune response can regulate the micro-
biota to mediate colonization resistance. ID2, an
essential transcriptional regulator for the develop-
ment of innate lymphoid cell (ILC) progenitors, re-
mains highly expressed in differentiated ILCs with
unknown function. Using conditionally deficient
mice in which ID2 is deleted from differentiated
ILC3s, we observed that thesemutantmice exhibited
greatly impaired gut colonization resistance against
Citrobacter rodentium. Utilizing gnotobiotic hosts,
we showed that the ID2-dependent early coloniza-
tion resistance was mediated by interleukin-22 (IL-
22) regulation of the microbiota. In addition to regu-
lating development, ID2 maintained homeostasis of
ILC3s and controlled IL-22 production through an
aryl hydrocarbon receptor (AhR) and IL-23 receptor
pathway. Thus, ILC3s can mediate immune sur-
veillance, which constantly maintains a proper mi-
crobiota, to facilitate early colonization resistance
through an ID2-dependent regulation of IL-22.
INTRODUCTION
Colonization resistance against pathogens is dependent on
direct inhibition by the host microbiota (van der Waaij et al.,
1971). The microbiota can also regulate the host immune
response to mediate indirect colonization resistance against
pathogens (Buffie and Pamer, 2013). In contrast, various host
genetic factors, including immune factors, also contribute to
the varying levels of individual susceptibility to pathogen infec-
tions (Chapman andHill, 2012;Wlodarska et al., 2014). However,
it is unclear whether and how such host genetic factors
contribute to colonization resistance against pathogens through
shaping the microbiota. Citrobacter rodentium (C. rodentium) isa natural mouse intestinal pathogen that mimics human Entero-
haemorrhagic Escherichia coli (E. coli) and Enteropathogenic
E. coli, which cause severe diarrhea (Crim et al., 2014; Ochoa
et al., 2008). Both innate and adaptive immune components,
including interleukin-22 (IL-22)-producing innate lymphoid cells
(ILCs), CD4+ T cells, B cells, and C. rodentium-specific anti-
bodies, are essential for controlling and eradicating the infection
(Bry and Brenner, 2004; Bry et al., 2006; Guo et al., 2014; Zheng
et al., 2008). Gut flora has been shown to be important in
protection against infection. C3H/HeOuJ mice suffer 100%mor-
tality after C. rodentium-induced colitis (Vallance et al., 2003),
whereas microbiota transfer from C57BL/6 mice leads to a com-
plete rescue of C3H/HeOuJmice fromdeath (Ghosh et al., 2011).
IL-22 is induced by IL-23 through the IL-23 receptor (IL-23R)-
STAT3 pathway in the early phase of infection and is essential for
host defense against C. rodentium infection (Guo et al., 2014;
Zheng et al., 2008). The major function of IL-22 is to promote
mucosal epithelial cell survival and proliferation and to trigger
the secretion of antimicrobial peptides, such as RegIIIg (Pickert
et al., 2009). Previous studies have also shown that exogenous
RegIIIg can partially rescue IL-22-deficient mice from death
(Zheng et al., 2008). Interestingly, in vitro assays suggest that Re-
gIIIg can only kill some Gram-positive bacteria, but not the
Gram-negative bacteria C. rodentium (Cash et al., 2006). There-
fore, it is still unknown how IL-22-induced RegIIIg controls
C. rodentium infection. Multiple studies have also shown that
IL-22 can shape the gut microflora, which contributes to protec-
tion or exacerbation of inflammatory bowel disease or infections
(Behnsen et al., 2014; Qiu et al., 2013; Zelante et al., 2013). How-
ever, it is not known whether IL-22 shapes the microbiota to
mediate early colonization resistance against C. rodentium.
Group 3 ILCs (ILC3s) are the major producer of IL-22 in the
naive gut (Guo et al., 2014; Qiu et al., 2012). ILCs are newly
defined immune cells that protect the host from various infec-
tions and include group 1 ILCs (ILC1s), group 2 ILCs (ILC2s),
and RORgt+ ILC3s (including CD4+ lymphoid tissue-inducer
[LTi] cells, natural cytotoxicity receptor (NCR) ILC3s, and
NCR+ ILC3s) (Spits et al., 2013). To date, the developmental
and functional program of ILC3s is known to involve transcription
factors, such as RORgt (Eberl and Littman, 2003; Eberl et al.,
2004), AhR (Kiss et al., 2011; Lee et al., 2012; Qiu et al., 2012),
and STAT3 (Guo et al., 2014). Recent data suggest that NCR+Immunity 42, 731–743, April 21, 2015 ª2015 Elsevier Inc. 731
ILC3s (NKp46+RORgt+ ILCs) might originate from NCR ILC3s
(Rankin et al., 2013; Vonarbourg et al., 2010). IL-7R signaling is
critical for the survival of ILC3s, but it also maintains RORgt
expression in mature NCR+ ILC3s (Schmutz et al., 2009; Vonar-
bourg et al., 2010).
E proteins belong to the bHLH transcription factor family,
which contains a basic DNA-binding region and a helix-loop-he-
lix (HLH) dimerization domain. They can form homodimers or
heterodimers with other HLH proteins and function as transcrip-
tion activators or repressors. Inhibitor of DNA-binding (ID) pro-
teins are HLH proteins that lack a basic region and can prevent
E proteins from binding to DNA. Both E and ID proteins play
important roles in lymphoid cell development (Kee, 2009). In
particular, ID2 is thought to be required for the development of
the ILC precursor given that Id2/ mice lack all the currently
known ILCs, including groups 1–3 (Boos et al., 2007; Hoyler
et al., 2012). ID2 is continuously and highly expressed in all
ILCs, including differentiated ILCs (Hoyler et al., 2012). However,
the function of ID2 in thesewell-differentiated ILCs is still unclear,
given that Id2/ mice lack ILCs from the earliest identifiable
stage. In this study, we used conditional deletion of Id2 after
RORgt expression in the ILC3 lineage to demonstrate that
continuous ID2 expression is required for the homeostasis and
function of ILC3s. Using this system, we showed that ILC3s
are essential for regulating the microbiota to mediate early colo-
nization resistance against intestinal pathogens.
RESULTS
ID2 Is Continuously Expressed in Intestinal ILCs
To test whether ID2 can function in differentiated ILCs, we first
analyzed ID2 expression in different ILC populations with
Id2GFP/+ mice. As previously reported (Cherrier et al., 2012; Hoy-
ler et al., 2012), ID2 was expressed in differentiated ILCs,
including natural killer (NK) cells, ILC1s, ILC2s, and ILC3s (Fig-
ure S1A). ID2 was not homogeneously expressed in the different
subsets of ILC3s. NCR+ ILC3s expressed higher concentrations
of ID2 than did LTi cells and NCR ILC3s (Figure S1B). Because
NCR+ ILC3s could be differentiated from NCR ILC3s (Rankin
et al., 2013; Vonarbourg et al., 2010), our findings raise the pos-
sibility that ID2 might continue to play a role in the development
and function of ILC3s after their formation.
To study the requirements for ID2 in the homeostasis and
function of differentiated ILC3s, we crossed Id2fl/fl mice with
Rorccre transgenic mice to achieve specific deletion of Id2 after
RORgt expression in ILC3s (RorccreId2fl/fl). Because RORgt is
transiently expressed at high levels at the double-positive stage
of T cell development,RorccreId2fl/fl mice lack ID2 expression not
only in RORgt+ ILC3s but also in most ab T cells (Figure S1C).
ID2 Is Essential for Early Colonization Resistance and
Protection against C. rodentium Infection
Previous studies have shown that ILC3s are essential for host
protection against C. rodentium infection (Guo et al., 2014; Qiu
et al., 2012). We next investigated the importance of ID2 for
ILC3 function in this infection model. After receiving high doses
of C. rodentium infection, RorccreId2fl/fl mice rapidly lost body
weight and died around day 10, whereas no weight loss or death
was observed in their littermate control Id2fl/fl mice (Figures 1A732 Immunity 42, 731–743, April 21, 2015 ª2015 Elsevier Inc.and 1B). Consistent with the increased morbidity and mor-
tality, bacterial titers were 103–1003 higher in the feces of
RorccreId2fl/fl mice than in the feces of Id2fl/fl mice at post-infec-
tion day 5 (Figure 1C). Systemic dissemination ofC. rodentium in
RorccreId2fl/fl mice, as evidenced by increased bacterial titers in
the blood, liver, and spleen, was also observed (Figures 1D and
1E). The RorccreId2fl/fl mice also exhibited severe diarrhea,
inflammation, and colon pathology upon C. rodentium challenge
(data not shown and Figure 1F). Collectively, these data demon-
strate that continued ID2 expression in RORgt+ cells is required
for host defense against C. rodentium infection.
Because disease signs, including diarrhea and loss of body
weight, appeared in ID2-deficient mice before post-infection day
5,wehypothesized that an ID2-dependentmechanism influenced
the intestinal environment to limit early colonization even before
the innate responsewas initiated. To test our hypothesis, we chal-
lenged both RorccreId2fl/fl and Id2fl/fl littermate mice with a low
dose of C. rodentium to determine whether RorccreId2fl/fl mice
were more readily colonized. Interestingly, there was significantly
more colonization of C. rodentium in the RorccreId2fl/fl mice in the
first few days, even as early as post-infection day 1, than in the
Id2fl/flmice (Figure1G).Moreover,C. rodentiumcouldbedetected
in the whole intestine of RorccreId2fl/fl mice even at post-infection
day 1, whereas it was detected only in the cecum of Id2fl/fl
mice (Figure S1D). Similar to mice infected with a high dose,
RorccreId2fl/fl mice infected with a low dose of C. rodentium had
severe diarrhea, rapidly lost body weight, and died around day
10, whereas Id2fl/fl mice were not affected (Figures 1H and 1I).
Together, our data indicate that ID2 is essential in RORgt+ cells
for host defense against a mucosal bacterial pathogen and is
required for maintenance of early colonization resistance.
Given that it takes a few days for an effective innate immune
response to control a pathogen, the impaired early colonization
resistance againstC. rodentium suggested that theRorccreId2fl/fl
mice had a pre-existing defect. Previous studies have shown
that either increased inflammation or a reduced mucus layer
could result in increased colonization of an intestinal pathogen
(Bergstrom et al., 2010; Wlodarska et al., 2011). However,
colonic mRNA analysis showed that there was no increased
expression of pro-inflammatory cytokines or reduction of mucin
in RorccreId2fl/fl mice (Figures S1E and S1F). Moreover, H&E and
PAS (periodic acid-Schiff) staining showed that there were no
obvious alterations of histopathology, mucus layers, or goblet
cells (Figure S1G). Together, these data suggest that the
increased C. rodentium colonization in our ID2-deficient mice
was unlikely to be due to changed colonic inflammation or
mucus environment.
The ID2-Dependent Microbiota Controls Colonization
Resistance against C. rodentium Infection
The host microbiota has been recognized as a direct mediator
for colonization resistance against pathogens (Buffie and
Pamer, 2013). To test whether ID2 regulates early C. rodentium
colonization through the microbiota, we first treated both Id2fl/fl
and RorccreId2fl/fl mice with antibiotics for 1 week and then in-
fected these mice with a low dose of C. rodentium after 1 day
of rest. As shown in Figure 2A, fecal C. rodentium titers in con-
trol-treated RorccreId2fl/fl mice were much higher than in Id2fl/fl
mice at days 1 and 3 after infection. However, bacterial titers
Figure 1. ID2 Is Essential for Mediating Colonization Resistance and Protection against C. rodentium Infection
(A–F) 7-week-old RorccreId2fl/fl (knockout [KO]) mice (n = 5) and their wild-type (WT) Id2fl/fl littermates (n = 5) were orally inoculated with a high dose (23 109 CFU)
of C. rodentium. Body-weight change (A) and survival rates (B) are shown. Fecal and blood C. rodentium titers at post-infection day 5 (C and D, respectively) and
C. rodentium titers from spleen and liver homogenate cultures at post-infection day 8 (E) are shown. The dashed line indicates the limit of detection. (F) His-
tological analysis of representative colons from WT and KO mice at post-infection day 8. Scale bars represent 100 mm.
(G–I) 7-week-old KOmice (n = 5) and their WT littermates (n = 5) were orally inoculated with a low dose (53 106 CFU) ofC. rodentium. (G) FecalC. rodentium titers
at the indicated post-infection day are shown. Body-weight change (H) and survival rates (I) are shown.
Each dot represents one individual mouse (C–E and G). Error bars represent the SEM. *p < 0.05; **p < 0.01; ***p < 0.001 (Student’s t test); nd, nondetectable. Data
are representative of three (A–D and G–I) or two (E and F) independent experiments. See also Figure S1.were increased in both the Id2fl/fl and RorccreId2fl/fl mice after
antibiotic treatment during the first few days after infection (Fig-
ure 2A). In addition, both Id2fl/fl and RorccreId2fl/fl antibiotic-
treated mice rapidly lost more body weight than did untreated
mice (Figure 2B). However, only a little systemic dissemination
ofC. rodentiumwas observed in the blood and liver of Id2fl/fl anti-
biotic-treated mice, despite high pathogen titers in the feces
(Figures 2A, S2A, and S2B). Together, these results suggest
that the microbiota is critical for early colonization resistance
against C. rodentium but that it has a limited effect on systemic
dissemination of the pathogen.
Our data led us to hypothesize that ID2 controls the
microbiota to maintain colonization resistance. To test thishypothesis, we reconstituted gnotobiotic C57BL/6 mice with
cecal content from Id2fl/fl or RorccreId2fl/fl mice by oral
inoculation. One day later, the reconstituted mice were chal-
lenged with a low dose of C. rodentium. As shown in Fig-
ure 2D, germ-free mice that did not receive a microbiota
transplantation exhibited very high fecal C. rodentium titers
even at day 1, whereas mice reconstituted with the Id2fl/fl mi-
crobiota showed markedly reduced C. rodentium titers.
Importantly, germ-free mice inoculated with RorccreId2fl/fl
cecal content showed higher C. rodentium titers than did
Id2fl/fl mice (Figure 2D). These data demonstrate that the
ID2-dependent microbiota controls colonization resistance
against C. rodentium.Immunity 42, 731–743, April 21, 2015 ª2015 Elsevier Inc. 733
Figure 2. The ID2-Dependent Microbiota Mediates Colonization Resistance against C. rodentium Infection
(A–C) 7-week-old RorccreId2fl/fl (KO) mice and their Id2fl/fl (WT) littermates were treated with either antibiotics (n = 5) or a control (n = 3) in drinking water for 1 week.
One day later, WT and KO mice were orally inoculated with 53 106 CFU of C. rodentium. Fecal C. rodentium titers at the indicated post-infection day (A), body-
weight change (B), and survival rates (C) are shown. Data are representative of two independent experiments.
(D–F) Germ-free (GF) WT B6 mice (D) or GF Ltbr/ mice (E and F) were colonized with the microbiota from either WT or KO littermate mice by gavage of cecal
material. One day later, these mice were orally inoculated with 5 3 106 CFU (D) or 1 3 107 CFU (E and F) of C. rodentium, and fecal C. rodentium titers were
examined at the indicated post-infection day (D and E). (F) Survival rates were monitored every day. Data were pooled from three independent experiments.
Each dot represents one individual mouse (A, D, and E). The dashed line indicates the limit of detection. Error bars represent the SEM. *p < 0.05; **p < 0.01;
***p < 0.001; ns, no significant difference (Student’s t test). See also Figure S2.The microbiota can also indirectly mediate colonization re-
sistance through regulation of host immune response (Buffie
and Pamer, 2013). Reconstitution of the microbiota in germ-
free mice will induce the host immune response, which might
result in increased indirect colonization resistance against
C. rodentium. We examined whether the different microbiota
from Id2fl/fl and RorccreId2fl/fl mice induce different host immune
responses of germ-free mice. As shown in Figure S2C, reconsti-
tution of Id2fl/fl and RorccreId2fl/fl microflora in germ-free mice
induced similar amounts of expression of pro-inflammatory cyto-
kines and antimicrobial proteins. Together, these data indicate
that early colonization resistance mediated by the ID2-depen-
dent microbiota might not be through the regulation of host
immune response.
Ltbr/ mice have multiple defects in innate and adaptive
immune responses, including reduced IL-22 and antibody pro-
duction, which are both essential for host protection against
C. rodentium infection (Kang et al., 2002; Spahn et al., 2004;
Tumanov et al., 2011; Wang et al., 2010). To further determine
whether the ID2-dependent microbiota can directly mediate
colonization resistance, we used Ltbr/ germ-free mice
as recipients. As observed in the C57BL/6 germ-free recip-
ient mice, the Ltbr/ germ-free mice repopulated with the
Id2fl/fl microbiota showed reduced C. rodentium colonization,
whereas the Ltbr/ mice repopulated with the RorccreId2fl/fl734 Immunity 42, 731–743, April 21, 2015 ª2015 Elsevier Inc.microbiota showed more C. rodentium colonization (Figure 2E).
Moreover, transplantation of the Id2fl/fl microbiota improved
the survival of Ltbr/ mice after C. rodentium challenge,
whereas Ltbr/ germ-free mice transferred with RorccreId2fl/fl
cecal content showed a mortality rate similar to that of the un-
treated Ltbr/ germ-free mice (Figure 2F). All together, these
data indicate that the microbiota mediates colonization resis-
tance, which is dependent on continued expression of ID2 in
RORgt+ cells.
To further understand how the ID2-dependent microbiota
regulates pathogen colonization, we examined the microbiome
by pyrosequencing with bacterial 16S rRNA genes. Analysis of
16S rRNA genes revealed that although there were no obvious
differences in the bacterial diversity and compositions at the
phyla level between Id2fl/fl and RorccreId2fl/fl mice (Figures
S2D and S2E), we observed that several operational taxonomic
units were over- and underrepresented in RorccreId2fl/fl mice
(Figure S2F). Furthermore, qPCR with primers specific to
different bacteria demonstrated that segmented filamentous
bacteria (SFBs) were overgrown in RorccreId2fl/fl mice (Fig-
ure S2G); these bacteria have been shown to induce the devel-
opment of T helper 17 (Th17) cells and be regulated by ILC3s
(Ivanov et al., 2009; Qiu et al., 2013). All together, our data
suggest that ID2 in RORgt+ cells regulates the intestinal
microbiota.
Figure 3. ID2 Mediates Colonization Resis-
tance against C. rodentium through IL-22-
Dependent Regulation of the Microbiota
(A) RorccreId2fl/fl (KO) mice and their Id2fl/fl (WT)
littermates were infected with 2 3 109 CFU of
C. rodentium. The mRNA expression of antimi-
crobial proteins IL-22, RegIIIg, and RegIIIb in the
colon of naivemice ormice on day 5 post-infection
was measured by real-time PCR. Data are repre-
sentative of two independent experiments (n = 3–5
per group; mean ± SEM).
(B and C) WT mice were injected intraperitoneally
with either anti-IL-22 antibody (8E11.9, 100 mg per
mouse per week, n = 5) or mouse IgG control
(n = 5) at 3, 4, or 5 weeks old. Two weeks later,
7-week-old WT and KO mice were orally infected
with a low dose (5 3 106 CFU) of C. rodentium.
Fecal C. rodentium titers at the indicated post-
infection day (B) and survival rates (C) are shown.
The dashed line indicates the limit of detection.
Data are representative of two independent
experiments.
(D and E) Germ-free (GF) WT B6 mice (D) or GF
Ltbr/ mice (E) were colonized with the micro-
biota from WT mice treated with either anti-IL-22
or mouse IgG by gavage of cecal material. One
day later, these mice were orally inoculated with a
low dose (53 106 CFU in D and 13 107 CFU in E)
ofC. rodentium, and fecalC. rodentium titers were
examined at the indicated post-infection day. Data
are representative of two (D) or three (E) inde-
pendent experiments.
Each dot represents one individual mouse (B, D,
and E). Error bars represent the SEM. *p < 0.05;
**p < 0.01; ***p < 0.001; ns, no significant differ-
ence (Student’s t test); nd, nondetectable. See
also Figure S3.ID2 Mediates Colonization Resistance against
C. rodentium through IL-22-Dependent Regulation of
the Microbiota
IL-22, mainly produced by RORgt+ cells, not only is required for
protection against pathogen infection but also regulates the ho-
meostasis of microflora in the intestine (Qiu et al., 2013; Qiu et al.,
2012). We tested whether ID2 mediates colonization resistance
through IL-22-dependent regulation of the microbiota. Id2fl/fl
and RorccreId2fl/fl mice were infected with C. rodentium, and
the expression of Il22 mRNA and mRNA encoding two IL-22-
dependent antimicrobial proteins (RegIIIg and RegIIIb) was
examined in both naive and infected colon tissues. As shown
in Figure 3A, compared with Id2fl/fl mice, RorccreId2fl/fl mice
showed significant reduction of Il22, Reg3g, and Reg3b mRNA
in both naive and infected states, indicating that continued
ID2 expression in RORgt+ cells is essential for IL-22 production
in the intestine. To test whether IL-22 regulates the microbiotaImmunity 42, 731–7to mediate early colonization resistance,
we treated Id2fl/fl mice with anti-IL-22
neutralization antibody at weaning and
challenged them with C. rodentium
when they were 7 weeks old. Similar to
theRorccreId2fl/fl mice, Id2fl/fl mice treated
with anti-IL-22 showed increased fecalC. rodentium amounts and decreased survival (Figures 3B and
3C), indicating that blocking IL-22 function early in life de-
stroys colonization resistance in adulthood. To further determine
whether early colonization resistance is mediated by the IL-22-
dependent microbiota, but not the C. rodentium-induced im-
mune response, we treated Id2fl/fl mice with anti-IL-22 antibody
7 days before or at the same day of infection. As shown in Fig-
ures S3A–S3C, although only early anti-IL-22 treatment resulted
in increased colonization of C. rodentium in feces, both anti-IL-
22-treated groups revealed increased C. rodentium colony-
forming units (CFU) in blood, spleen, and liver. Our earlier data
in this study showed that the antibiotic-treated microbiota
dramatically reduced early colonization resistance against
C. rodentium, but not systemic dissemination (Figures S3A and
S3B). Thus, our data indicate that IL-22 not only mediates colo-
nization resistance against intestinal pathogen through regula-
tion of microbiota but also controls the systemic dissemination43, April 21, 2015 ª2015 Elsevier Inc. 735
Figure 4. IL-22-Producing ILCs Mediate
ColonizationResistanceagainstC. rodentium
(A) IL-22 expression in CD3 and CD3+ cells was
analyzed by intracellular cytokine staining. Intestinal
LPLs were isolated from the colons of naive Id2fl/fl
(WT) orRorccreId2fl/fl (KO)mice, stimulatedwith IL-23
(25 ng/ml) for 4 hr, and gated in Thy1+ lymphocytes.
Data are representative of at least five independent
experiments.
(B) RORgt+ ILC3s and T helper cells were purified by
flow cytometric sorting from intestinal LPLs of
RorcGFP/+ mice. The mRNA expression of IL-22 was
measured by real-time PCR. Data are representative
of two independent experiments (mean ± SEM of
triplicate samples of real-time PCR).
(C and D) Rag1/ mice were injected intraperito-
neally with either anti-CD90 antibody (30H12, 100mg
per mouse each time) or rat IgG control at days10
and5 before infection for depletion of ILCs (n = 5).
Ten days later,micewere orally infectedwith 13 107
CFU ofC. rodentium. FecalC. rodentium titers at the
indicated post-infection day (C) and survival rates (D)
are shown. Data are representative of two indepen-
dent experiments. Each dot represents one individ-
ual mouse (C).
(E and F) KO mice were injected with innate cells
at weaning. Four weeks later, WT and KO mice
were orally infected with 5 3 106 CFU of
C. rodentium. Fecal C. rodentium titers at the indi-
cated post-infection day (E) and survival rates (F)
are shown. The dashed line indicates the limit of
detection. Data are representative of two indepen-
dent experiments.
Error bars represent the SEM. *p < 0.05; **p < 0.01;
***p < 0.001 (Student’s t test). See also Figure S4.of pathogen, which is less microbiota dependent. Consistent
with this, RorccreStat3fl/fl mice, which lack IL-22 production
from RORgt+ cells, also exhibited impaired early colonization
resistance (Figure S3D). To further test the requirement for
IL-22 to maintain a protective microbiota, we transplanted
germ-free C57BL/6 and Ltbr/ mice with microflora from the
anti-IL-22-treated or control mice and challenged them with
C. rodentium. As observed with germ-free mice repopulated
with the microbiota from RorccreId2fl/fl mice, the microbiota
from anti-IL-22-treated mice failed to prevent colonization by736 Immunity 42, 731–743, April 21, 2015 ª2015 Elsevier Inc.C. rodentium (Figures 3D and 3E). Col-
lectively, our results suggest that ID2
mediates colonization resistance against
C. rodentium through IL-22-dependent
regulation of the microbiota.
IL-22-Producing ILCs Are
Necessary and Sufficient to
Mediate Colonization Resistance
against C. rodentium
Although IL-22 can be produced by both
ILC3s and T cells, we observed that
ILC3s were the main producer of IL-22
in the naive state (Figures 4A and 4B)and that innate IL-22 production was markedly reduced in ID2-
deficient mice (Figure 4A). This IL-22 expression profile suggests
that ILC3s might be responsible for colonization resistance. To
test our hypothesis, we depleted ILCs with anti-CD90 antibody
in Rag1/mice 1 week before infection. Compared with control
mice, ILC-depleted Rag1/ mice showed increased early
C. rodentium colonization (Figure 4C) and a decreased lifespan
after infection (Figure 4D). Furthermore, innate cells from the
intestine of Rag1/ mice were isolated and transferred into
RorccreId2fl/fl mice at weaning. Consistent with our hypothesis,
innate cells restored the expression of IL-22 and colonization
resistance against C. rodentium in RorccreId2fl/fl mice and
completely rescued the RorccreId2fl/fl mice from death (Figures
4E, 4F, and S4A). Together, these results demonstrate that IL-
22-producing ILCsmediate early colonization resistance against
an intestinal pathogen.
Continued Expression of ID2 Is Required for ILC3
Development and Maintenance
Because ID2 expression in ILC3s is essential for IL-22-depen-
dent regulation of the microbiota against pathogen colonization,
we next determined how ID2 regulates IL-22 production by
ILC3s and whether ID2 regulates ILC3 homeostasis or function-
ality. ID2 is required for the development of all ILC precursors;
thus, first we tested whether ID2 is still important for further
development of ILC3s. Id2fl/fl and RorccreId2fl/fl mice were
crossedwithRorcGFP/+ mice, and ILC3s were examined in the in-
testinal lamina propria leukocytes (LPLs). RORgt-expressing
ILC3s were dramatically reduced in both the large and small in-
testines in RorcGFP/+RorccreId2fl/fl mice, and the remaining ILC3s
were mostly CD4+ LTi cells and NCR ILC3s (Figures 5A–5C,
S5A, and S5B). Previous studies have shown that NCR+ ILC3s
can develop from NCR ILC3s and that IL-7R signaling is
required for this further development, as well as for the survival
and proliferation of ILCs (Schmutz et al., 2009; Vonarbourg
et al., 2010). We found that ID2-deficient ILC3s had diminished
IL-7Ra expression at both the protein and mRNA levels (Figures
5D and 5E).
To further determine the role of ID2 in ILC3 maintenance, we
sorted both wild-type (WT) and RorccreId2fl/fl ILC3s from
CD45.1+ C57BL/6 and CD45.2+ RorccreId2fl/fl mice and injected
them into Rag2/Il2rg/ mice at a 1:1 ratio. The gut LPLs
were isolated 4 weeks later, and flow cytometric analysis
revealed that WT ILC3s were 4-fold more abundant than
RorccreId2fl/fl cells (Figure S5C). Moreover, we found that
ID2-deficient ILC3s exhibited increased apoptosis and reduced
Bcl-2 expression, which is considered an important anti-
apoptotic protein (data not shown and Figure S5D). Given that
ID2 is required for the development of all ILCs and that early
developmental defects might also result in dramatic reduction
of adult ILC3s (Cherrier et al., 2012), we further isolated the fetal
liver cells to examine whether ID2 is required for the develop-
ment rather than the maintenance of ILC3s. As shown in Figures
5F and 5G, there was no reduction of fetal LTi cells in the liver of
RorccreId2fl/fl mice. However, similar to adult ILC3s, ID2-deficient
fetal ILC3s also exhibited reduced expression of IL-7Ra (Figures
5H and 5I). Together, our results clearly demonstrate that
ID2 expression continues to be required in ILC3s after expres-
sion of RORgt for proper expression of IL-7Ra and ILC3
maintenance.
ID2 Regulates IL-22 Production by ILC3s through the
IL-23R Pathway
Multiple transcription factors, such as RORgt, AhR, andGATA-3,
regulate ILC3 development and function (Qiu et al., 2012; Sera-
fini et al., 2014). To further test whether ID2 also regulates the
function of ILC3s, we isolated both Id2fl/fl and RorccreId2fl/fl
LPLs from the intestine and examined IL-22 production. Inter-
estingly, the residual ID2-deficient ILC3swere unable to produceIL-22 after IL-23 stimulation (Figures 6A and 6B). This was also
confirmed by the observation that IL-22 production in LTi cells
and NCR ILC3s sorted from RorcGFP/+RorccreId2fl/fl mice was
markedly lower than that in RorcGFP/+Id2fl/fl ILC3s (Figures 6C
and S6A). Together, these data suggest that ID2 also plays an
essential role in regulating the function of ILC3s.
Previous studies have shown that IL-23 can interact with
IL-23R and activate STAT3. RORgt, AhR, and STAT3 can bind
to Il22 and directly promote IL-22 production (Guo et al., 2014;
Qiu et al., 2012). To determine how ID2 regulates ILC3s produc-
ing IL-22, we first examined the expression of these transcription
factors and cytokine receptor. LTi cells and NCR ILC3s were
purified from both RorcGFP/+ and RorcGFP/+RorccreId2fl/fl mice.
Consistent with a previous study (Zhang et al., 2014), ID2-defi-
cient LTi cells showed increased RORgt expression. The expres-
sion of AhR was reduced in both ID2-deficient resting LTi cells
and NCR ILC3s, but not IL-23-activated LTi cells. Interestingly,
the expression of IL-23R and STAT3 was reduced in both
ID2-deficient LTi cells and NCR ILC3s (Figures 6D and S6A).
Moreover, ID2-deficient fetal liver LTi cells also showed signifi-
cant reduction of IL-22 and IL-23R (Figure S6B), suggesting
that early ID2 regulation of IL-22 might be through the IL-23R-
STAT3 pathway.
ID proteins are transcription factors that inhibit the function of
theEprotein transcription factorsbypreventing themfrombinding
toDNA.Previous studies have shown that ID2 regulates thedevel-
opment of NK and LTi cells through suppression of E2A, also
known as TCF3 (Boos et al., 2007). To test whether ID2 also regu-
lates IL-22 production through suppression of E2A, we infected
EL4cellswith retrovirusexpressingeither ID2orE47 (oneEprotein
encodedbyE2A, alsoknownasTcf3) andexamined IL-22produc-
tion. Because RORgt is the master regulator for IL-22 production,
we also infected the EL4 cells with or without RORgt-expressing
retrovirus. As shown inFigures 6Eand6F, compared to thecontrol
group (with empty MigR retrovirus), EL4 cells infected with ID2
retrovirus produced more IL-22, whereas the E47 group showed
reduced IL-22 production with or without RORgt expression.
Moreover, increased expression of ID2 also caused increased
IL-23R and STAT3 expression in EL4 cells, whereas overexpres-
sion of E47 inhibited IL-23R expression. Together, our data indi-
cate that E2A might regulate IL-22 production through suppres-
sion of the IL-23R pathway and that ID2 promotes IL-22
production through suppression of E2A activity.
Next we wanted to determine how E2A inhibits IL-22 produc-
tion. Previous studies have shown that AhR-deficient ILC3s,
similar to ID2-deficient ILC3s, show reduced IL-7Ra and IL-23R
expression (Qiu et al., 2012). In addition, AhR is a member of
the bHLH transcription factor family. Although there was a slight
reduction of AhR expression in ID2-deficient ILC3s, we also
considered the possibility that E2A could interactwith AhR to pre-
vent its transcriptional activity and thus result in a reduction of IL-
22 in ID2-deficient ILC3s. Indeed, using EL4 cells expressing the
double-FLAG-epitope-tagged (DFTC) AhR with or without E47,
we detected an interaction between AhR and E2A by coimmuno-
precipitation (Figure 6G). Furthermore, a chromatin immunopre-
cipitation (ChIP) assay revealed that E2A could suppress AhR
binding to Il22 in EL4 cell lines (Figure 6H). Together, these data
suggest that E2A might regulate IL-22 production by directly
binding to AhR and preventing its transcription activity at Il22.Immunity 42, 731–743, April 21, 2015 ª2015 Elsevier Inc. 737
Figure 5. Continued Expression of ID2 Is Required for Further Development and Maintenance of ILC3s
(A and D) Small intestinal LPLs were isolated from 4-week-old RorcGFP/+Id2fl/fl (WT) and RorcGFP/+RorccreId2fl/fl (KO) mice and gated in live CD90+CD3 ILCs. (A)
Different populations of ILCs were analyzed by flow cytometry. Numbers adjacent to outlined areas indicate the percentage of cells in each gate. (D) The
expression of IL-7Ra on different ILCs was analyzed by flow cytometry. Data are representative of three independent experiments. ILCs and their corresponding
markers are as follows: NCR+ ILC3s, Nkp46+CD4RORgt+ ILCs; LTi cells, Nkp46CD4+RORgt+ ILCs; NCR ILC3s, Nkp46CD4RORgt+ ILCs; NK cells,
Nkp46+RORgt ILCs; and ILC2s, RORgtNkp46 ILCs.
(B and C) The percentage of different ILC3s in the CD90+CD3 ILCs and the absolute numbers of RORgt+ ILC3s in the small intestine of Id2fl/fl (WT) and
RorccreId2fl/fl (KO) mice are shown. Each dot represents one individual mouse. Data are pooled from two independent experiments (mean ± SEM).
(E) Small intestinal LPLs were isolated from 4-week-old RorcGFP/+Id2fl/fl (WT) and RorcGFP/+RorccreId2fl/fl (KO) mice. LTi cells and NCR ILC3s were purified by
flow cytometric sorting. ThemRNA expression of IL-7Rawasmeasured by real-time PCR. Data are representative of two independent experiments (mean ± SEM
of triplicate samples of real-time PCR).
(F and G) LTi cells in fetal liver were analyzed by flow cytometry. Embryonic day 14 and 15 fetuses were isolated and genotyped by PCR. (F) Fetal liver cells were
isolated from RorcGFP/GFP, Id2fl/fl, and RorccreId2fl/fl fetuses and gated in LinCD45+c-Kit+IL-7Ra+ ILCs. Numbers adjacent to outlined areas indicate the per-
centage of cells in each gate. Data are representative of four independent experiments. (G) The percentage of LTi cells (a4b7+RORgt+) in the LinCD45+c-Kit+IL-
7Ra+ cells from (F) is shown. Each dot represents one individual mouse. Data are pooled from four independent experiments (mean ± SEM).
(legend continued on next page)
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DISCUSSION
Host sequential responses from innate and adaptive immune
cells are essential for late-stage colonization resistance and
clearance of pathogens. Here, our study demonstrates that the
microbiota is important for early colonization resistance ahead
of innate and adaptive responses. Fecal microbiota transplanta-
tion has been successfully used in some patients with Clos-
tridium difficile infection (Austin et al., 2014). However, because
the stability of the gut microbiota is dependent onmany host and
environmental factors (Lozupone et al., 2012), it remains unclear
how a stable healthy microbial community should be introduced
to prevent recurrent infection. Our results further demonstrate
that baseline IL-22 production by ILC3s can regulate gut micro-
bial homeostasis to promote colonization resistance against
pathogens. Therefore, innate immunity contributes to coloniza-
tion resistance not only by rapidly responding after invasion
but also by maintaining the proper microbiota to limit coloniza-
tion before invasion. Our study suggests that a combination of
microbiota transplantation and immune molecule treatment
might restore a stable microbial community to prevent intestinal
pathogen colonization.
Commensals have been shown to utilize several different
mechanisms to directly mediate colonization resistance against
pathogens, including competing for niches and nutrients,
altering host environmental conditions (for example, pH), pro-
ducing bacteriocins, and affecting pathogen virulence by O2
consumption and production of specific metabolites such as
the short-chain fatty acid (Kamada et al., 2013). Previous studies
have shown that E. coli can directly compete with C. rodentium
for nutritional resources and help the host to clear the pathogen
(Kamada et al., 2012). Repopulation of SFBs partially protects
Jackson B6 mice from C. rodentium infection (Ivanov et al.,
2009). However, we detected very few E. coli in the mice housed
in our specific-pathogen-free facility, and the SFB level was
greatly increased in conditional ID2-deficient mice, consistent
with other IL-22 deficient mice (Qiu et al., 2013; Upadhyay
et al., 2012). Thus, IL-22-dependent colonization resistance is
not mediated through E. coli and SFB. It remains to be deter-
mined which commensals are regulated by innate IL-22 for colo-
nization resistance and how commensals suppressC. rodentium
colonization, which might lead to discovery of novel therapeutic
probiotics and prebiotics.
Notch, ID2, and RORgt sequentially orchestrate the develop-
ment of ILC3s (Cherrier et al., 2012). However, the function of
the highly expressed ID2 in differentiated ILCs is unclear. Our
data clearly demonstrate that themaintenance of ID2 expression
is required for further development and function of ILC3s.
Consistent with the role of ID2 on IL-7Ra regulation in CD4+ thy-
mocytes (Jones-Mason et al., 2012), we found that ID2 controls
IL-7Ra expression in ILC3s, but how ID2 regulates IL-7Ra re-
mains to be determined. Given that IL-7R signaling is also essen-
tial for the homeostasis of the other ILCs (Hoyler et al., 2012), our(H) The expression of IL-7Ra on different fetal liver cells was analysis by flow cyto
then gated in either a4b7+RORgt+ LTi cells or a4b7+RORgt LTi precursor cells.
(I) Fetal LTi cells were purified by flow cytometric sorting from fetal liver cells of Ro
was measured by real-time PCR. Data are representative of two independent ex
*p < 0.05; **p < 0.01; ***p < 0.001; ns, no significant difference (Student’s t test).results suggest that ID2 might globally and constantly regulate
the ILC lineage from progenitor to effector ILCs.
After IL-23 stimulation, STAT3, AhR, and RORgt can be re-
cruited to Il22 to promote IL-22 production. It has been shown
that AhR requires interaction with RORgt to bind to Il22. Without
RORgt, there is only a little recruitment of AhR to Il22 (Guo et al.,
2014; Qiu et al., 2012). Consistently, our data confirm that AhR
weakly binds to Il22 without overexpressing RORgt. However,
E2A physically interacted with AhR and completely blocked the
binding of AhR to Il22. Our studies suggest that two bHLH tran-
scription factors, E2A and AhR, might form a heterodimer that
either fails to bind DNA or has a DNA-binding specificity different
from that of the AhR-RORgt dimer. Therefore, an essential role of
ID2 might be to liberate AhR from E2A and allow AhR to bind to
other transcriptional activators, such as RORgt. Whether E2A
also interrupts the interaction between AhR and RORgt remains
to be examined. We also showed that ID2 is required for expres-
sion of IL-7Ra and IL-23R. Given that AhR-deficient ILC3s also
exhibit impaired expression of these two cytokine receptors
(Qiu et al., 2012), E2A might also suppress their expression
through its interaction with AhR; however, an complete under-
standing of the molecular mechanism by which E2A affects
gene expression in ILC3s requires further investigation.
Taken together, our studies demonstrate several important
findings: (1) ID2 is essential not only for ILC lineage specification
but also for themaintenance and further development of RORgt+
ILC3s; (2) ID2-E2A interaction regulates the function of IL-22
production in ILC3s through the AhR and IL-23R pathway; and
(3) IL-22-producing ILC3s are essential for the maintenance of
the proper microbiota to mediate early colonization resistance
against pathogens. Proper addition of immune molecule treat-
ment to fecal microbiota transplantation might help the host to
reestablish a more stable and healthier microbial community in
patients with recurrent gut infection.EXPERIMENTAL PROCEDURES
Mice
C57BL/6 and Rag1/ mice were purchased from Harland Teklad.
Rag2/Il2rg/, RorcGFP/+ (Eberl et al., 2004), and Id2GFP/+ (Rawlins et al.,
2009) mice were purchased from The Jackson Laboratory. Crossing Id2fl/fl
mice (Niola et al., 2012) with Rorccre transgenic mice (Eberl and Littman,
2004) generated RorccreId2fl/fl mice. All mice were on a C57BL/6 background.
Germ-free Ltbr/ mice were rederived in Taconic. All germ-free mice were
maintained in the gnotobiotic facility at The University of Chicago. Animal
care and use were in accordance with institutional and NIH guidelines, and
all studies were approved by the animal care and use committee of The Univer-
sity of Chicago.
Infection with C. rodentium and Treatment
Mice were orally gavaged with C. rodentium strain DBS100 (ATCC 51459;
American Type Culture Collection), and body weight, survival, CFU counts, tis-
sue histology, and PAS staining were assessed as previously described (Tu-
manov et al., 2011; Wang et al., 2010). Where indicated, mice were treated
with antibiotics (1 g/l ampicillin, 1 g/l neomycin, 1 g/l metronidazole, and 0.5metry. The fetal liver cells were gated in LinCD45+c-Kit+IL-7Ra+ cells first and
Data are representative of four independent experiments.
rcGFP/+Id2fl/fl and RorcGFP/+RorccreId2fl/fl mice. The mRNA expression of IL-7Ra
periments (mean ± SEM of triplicate samples of real-time PCR).
See also Figure S5.
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Figure 6. ID2 Regulates IL-22 Production by ILC3s through the IL-23R Pathway
(A) Intestinal LPLs were isolated from naive Id2fl/fl (WT) or RorccreId2fl/fl (KO) mice and stimulated with IL-23 (25 ng/ml) for 4 hr. IL-22 expression in
CD3CD90hiCD45loCD4+ LTi cells or CD3CD90hiCD45loCD4 ILC3s was analyzed by intracellular cytokine staining followed by flow cytometry. Data are
representative of three independent experiments.
(B) Percentages of IL-22-producing cells in LTi cells are shown. Colonic LPLs were isolated from C. rodentium-infected WT or KO mice at post-infection day 5,
restimulated with IL-23, and gated in CD3CD90hiCD45loCD4+ LTi cells. Each dot represents one individual mouse. Data were pooled from two independent
experiments (mean ± SEM).
(legend continued on next page)
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g/l vancomycin) in drinking water for 1 week and then infected with
C. rodentium after 1 day’s rest. Where indicated, mice were injected intraper-
itoneally with either anti-IL-22 antibody (8E11.9) or mouse immunoglobulin G1
(IgG1) as an isotype control (100 mg per mouse) by 3, 4, or 5 weeks of age or on
the indicated day. Then themice were infected withC. rodentium at 7 weeks of
age. For depletion of ILCs, Rag1/ mice were injected intraperitoneally with
anti-CD90 antibody (30H12, 100 mg per mouse) or rat IgG 10 days before
C. rodentium infection. Where indicated, innate cells were isolated from the in-
testine of Rag1/ mice and transferred by intravenous injection (1 3 106
innate cells or 2 3 105 purified CD45loCD90hi ILC3s per mouse) into 3- to 4-
week-old RorccreId2fl/fl mice.
Germ-Free Experiments
C57BL/6 or Ltbr/ germ-free mice were transferred to a specific-pathogen-
free environment and immediately gavaged with fresh cecal contents from
Id2fl/fl and RorccreId2fl/fl littermate donors or mice treated with anti-IL-22 anti-
body or an isotype control. One day later, these microflora-reconstituted mice
were infected with C. rodentium (Ahern et al., 2014).
Isolation of Intestinal LPLs and Fetal Liver Cells
The intestinal LPLs were isolated by the Lamina Propria Dissociation Kit (Mil-
tenyl Biotec) according to the manufacturer’s recommendations. Fetal liver
cells were dissociated by mechanical shearing in PBS containing 0.5% bovine
serum and then filtered through a 70-mM mesh.
Flow Cytometry, Antibodies, and ELISA
Antibodies against a lineage marker, CD3, CD4, CD45, CD90, Nkp46, CD117,
CD127, a4b7, RORgt, and streptavidin-APC were purchased from BioLegend
or eBioscience. Anti-IL-22 antibody was a gift from Genentech. For nuclear
staining, cells were fixed and permeabilized with the Transcription Factor
Staining Buffer Set (eBioscience). For cytokine production, cells were stimu-
lated ex vivo by IL-23 (25 ng/ml; R&D Systems) for 4 hr. IC Fixation Buffer
and Permeabilization Buffer (eBioscience) were used for intracellular cytokine
staining. Flow cytometry was performed on LSR-Fortessa instruments (BD
Biosciences) and analyzed with FlowJo software (Tree Star). ILC3s were
sorted from the intestinal LPLs and fetal liver cells on a FACSAria III instrument
(BD Biosciences). IL-22 in supernatants was measured by ELISA according to
the manufacturer’s (R&D Systems) recommendations.
Quantitative Real-Time RT-PCR
RNA isolation and real-time PCR were performed as previously described
(Guo et al., 2014) with different primer sets (Table S1).
Retroviral Transduction of Cell Lines
The retroviruses expressing MigR, ID2, E47, and RORgt were made as previ-
ously described (Qiu et al., 2012). EL4 cells were infected with 2 ml of virus su-
pernatant (MigR, ID2, or E47), and 48 hr later, the GFP+ infected cells were
sorted on the Avalon Cell Sorter (Propel Labs). The sorted EL4 cells were
then infected with a retrovirus expressing either MigR or RORgt. Cell-culture
supernatant and cell RNA were analyzed by ELISA and real-time PCR
separately.
Co-immunoprecipitation and ChIP
EL4 cells were infected with DFTC AhR retroviral vector and selected in the
presence of 7 mg/ml puromycin. EL4 cells stably expressing AhR were then in-(C and D) LTi cells and NCR ILC3s were purified by flow cytometric sorting fro
directly for RNA extraction. The mRNA expression of IL-22 (C) and RORgt, AhR, IL
of two independent experiments (C and D) (mean ± SEM of triplicate samples of
(E and F) EL4 cells were infected with ID2 or E47 expression or control retrovirus w
(E) The production of IL-22 in the cell-culture supernatant was measured by ELISA
time PCR. Error bars represent the SEM of triplicate samples. Data are represen
(G) E2A physically interacted with AhR. EL4 cells were stably infected with the in
with anti-FLAG beads and subsequently immunoblotted with anti-E2A antibodie
(H) EmptyMigR or E47 was coexpressed by retroviral transduction in EL4 cell lines
by ChIP assay. Data are representative of two independent experiments (mean ±
*p < 0.05; **p < 0.01; ***p < 0.001; ns, no significant difference (Student’s t test);fected with a retrovirus expressing either MigR or E47. The GFP+ infected cells
were sorted, and the whole-cell lysate supernatant was immunoprecipitated
with EZview Red Anti-FLAG Affinity Gel (Sigma-Aldrich). Immunoblotting
was performed with anti-E2A rabbit antibody (Thermo Scientific) and anti-
GAPDH antibody (Sigma-Aldrich). ChIP assays with EL4 cells were performed
as previously described (Qiu et al., 2012).
Statistical Methods
Statistical analysis was performed by a two-tailed Student’s t test in the
GraphPad Prism 5.0 program. Data from such experiments are presented as
mean values ± SEM; p < 0.05 was considered significant. For survival curves,
statistics were done with the log-rank (Mantel-Cox) test.
SUPPLEMENTAL INFORMATION
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